Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▲ | 5y |
|---|---|---|---|---|---|---|---|
| Otsuka Holdings Co. Ltd. | -0.530% | -3.093% | 1.622% | 16.049% | 13.253% | 16.049% | 20.224% |
| Amicus Therapeutics Inc. | -1.690% | 1.156% | -11.616% | -11.616% | -34.211% | 16.667% | - |
| Guerbet S.A. | -0.810% | -2.273% | 13.509% | 106.264% | 89.575% | 19.250% | -23.775% |
| Alnylam Pharmace. | -0.730% | 0.622% | 1.512% | -20.554% | -22.260% | 20.175% | 129.831% |
| Halozyme Therapeutics Inc. | 1.830% | 3.580% | 15.660% | 33.854% | 23.929% | 21.103% | - |
| Alkermes plc | 0.910% | -0.893% | 0.000% | -20.714% | -11.200% | 21.978% | -0.893% |
| Blueprint Medicines Corp | -1.980% | -2.133% | 16.994% | 87.098% | 15.661% | 23.569% | - |
| WAVE Life Sciences Ltd | 0.000% | 8.491% | 26.096% | 70.118% | 25.546% | 24.405% | - |
| Ardelyx Inc. | -1.500% | -0.973% | 16.896% | 117.256% | 23.287% | 25.018% | - |
| GSK plc | -0.870% | -2.672% | 9.707% | 24.118% | 21.718% | 26.708% | 16.625% |
| Virbac S.A. | 1.430% | -1.395% | -3.810% | 16.667% | -1.532% | 29.725% | 115.812% |
| Arbutus Biopharma Corp. | 1.610% | 11.480% | 14.864% | 23.774% | 28.627% | 30.044% | 39.180% |
| Syndax Pharmaceuticals Inc | -0.530% | -9.048% | -6.373% | -1.546% | 2.139% | 30.822% | - |
| Innoviva Inc. | 0.000% | -1.342% | 6.522% | 17.600% | 0.685% | 36.111% | - |
| Amgen Inc. | 0.430% | 0.782% | 14.894% | 40.256% | 11.301% | 40.801% | 90.297% |
| Ipsen S.A. | -0.910% | -0.164% | 12.292% | 6.392% | 13.340% | 42.941% | 9.263% |
| EyePoint Pharmaceuticals Inc. | -2.170% | -3.972% | -33.860% | 94.286% | -49.159% | 45.067% | - |
| Corcept Therapeutics Inc. | 3.480% | 5.121% | 26.185% | 20.045% | -10.367% | 51.921% | - |
| Celldex Therapeutics | 0.000% | -6.452% | -3.867% | 13.725% | -3.867% | 53.982% | 555.367% |
| AstraZeneca plc | 3.180% | 2.492% | 13.707% | 4.998% | 19.476% | 54.204% | 116.264% |